Literature DB >> 21814734

Evaluation of bacterial adherence and biofilm arrangements as new targets in treatment of chronic rhinosinusitis.

Ahmed Ragab1, Nira Essa, Nahed El-Raghy, Wafaa Zahran, A El Borolsy.   

Abstract

Several promising candidate drugs that target bacterial adherence and biofilm formation are being developed. Such hopeful drugs cannot be studied in chronic rhinosinusitis (CRS) without the evaluation of such virulence criteria in different forms of the disease with and without nasal polyposis (CRSwNP and CRSsNP). The aim of this study was to evaluate bacterial adherence, response to antibiotics and degree of accumulation of bacterial biofilms as new targets of treatment in CRSwNP and CRSsNP. Twenty CRS patients and 10 normal subjects with airway obstructing concha bullosa were prospectively enrolled in the present study. Scanning electron microscopy and cultures were performed on paranasal sinus tissue samples. Bacterial adherence tests using the tissue culture plate method were measured quantitatively. Strongly adherent bacteria were identified significantly in 6/9 (77%) cases of CRSsNP in comparison to 1/7 (14%) cases of CRSwNP. Strongly adherent bacteria that were sensitive to ciprofloxacin, vancomycin, and impenim were identified in 75% of the cultured coagulase positive staphylococci. A significant difference (P = 0.007) in the degree of accumulation of bacterial biofilms existed between the two groups. In CRSsNP, a more advanced stage of bacterial biofilms with strong bacterial adherence was observed which make them attractive targets for new drugs. In CRSwNP, lower stage bacterial biofilms with low bacterial adhesion were identified, which may help explain the low bacterial virulence in an environment of suboptimal, organizational arrangements.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814734     DOI: 10.1007/s00405-011-1715-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  Correlation between the cytology of the nasal middle meatus and BAL in chronic rhinosinusitis.

Authors:  Ahmed Ragab; Peter Clement; Walter Vincken
Journal:  Rhinology       Date:  2005-03       Impact factor: 3.681

2.  Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis.

Authors:  Zohra Bendouah; Jean Barbeau; Walid Abou Hamad; Martin Desrosiers
Journal:  Otolaryngol Head Neck Surg       Date:  2006-06       Impact factor: 3.497

3.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

Review 4.  Implications of bacterial biofilms in chronic rhinosinusitis.

Authors:  Edwin Tamashiro; Marcelo B Antunes; James N Palmer; Noam A Cohen; Wilma T Anselmo-Lima
Journal:  Braz J Infect Dis       Date:  2009-06       Impact factor: 1.949

5.  Bacterial cultures of the middle meatus and bronchoalveolar lavage in chronic rhinosinusitis.

Authors:  Ahmed Ragab; Peter Clement; Walter Vincken
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-11-24       Impact factor: 1.538

6.  Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms?

Authors:  Jacopo Galli; Lea Calò; Fausta Ardito; Micaela Imperiali; Ezio Bassotti; Giulio Cesare Passali; Giuseppe La Torre; Gaetano Paludetti; Giovanni Fadda
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-12       Impact factor: 1.547

7.  Characterization of bacterial and fungal biofilms in chronic rhinosinusitis.

Authors:  Andrew Foreman; Alkis James Psaltis; Lor Wai Tan; Peter-John Wormald
Journal:  Am J Rhinol Allergy       Date:  2009 Nov-Dec       Impact factor: 2.467

8.  Biofilms correlate with TH1 inflammation in the sinonasal tissue of patients with chronic rhinosinusitis.

Authors:  Adrianna M Hekiert; Jennifer M Kofonow; Laurel Doghramji; David W Kennedy; Alexander G Chiu; James N Palmer; Jeffery G Leid; Noam A Cohen
Journal:  Otolaryngol Head Neck Surg       Date:  2009-10       Impact factor: 3.497

9.  Chronic rhinosinusitis with and without nasal polyps: what is the difference?

Authors:  Wouter Huvenne; Nicholas van Bruaene; Nan Zhang; Thibaut van Zele; Joke Patou; Philippe Gevaert; Sofie Claeys; Paul Van Cauwenberge; Claus Bachert
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

10.  Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro.

Authors:  Martin Desrosiers; Zohra Bendouah; Jean Barbeau
Journal:  Am J Rhinol       Date:  2007 Mar-Apr
View more
  5 in total

1.  Biofilms in chronic rhinosinusitis with polyps: is eradication possible?

Authors:  Hakan Korkmaz; Bülent Ocal; Emel Cadallı Tatar; Ilkan Tatar; Ali Ozdek; Güleser Saylam; Hakan Hamdi Celik
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-08       Impact factor: 2.503

Review 2.  Role of biofilm in children with recurrent upper respiratory tract infections.

Authors:  E Nazzari; S Torretta; L Pignataro; P Marchisio; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-16       Impact factor: 3.267

Review 3.  The Effect of Spray Cryotherapy on Microbial Biofilms in Chronic Rhinosinusitis.

Authors:  Diana Vlad; Alina Dutu; Anda Apostol; Veronica Trombitas; Adrian Mihalca; Silviu Albu
Journal:  Curr Infect Dis Rep       Date:  2018-08-13       Impact factor: 3.725

4.  The pathophysiological role of bacterial biofilms in chronic sinusitis.

Authors:  Jolanta Dlugaszewska; Malgorzata Leszczynska; Marcin Lenkowski; Agnieszka Tatarska; Tomasz Pastusiak; Witold Szyfter
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

Review 5.  Definition and management of odontogenic maxillary sinusitis.

Authors:  Soung Min Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.